An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Tanta University, Tanta, ElGharbia, Egypt
Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Ainshams University, Cairo, Egypt
Istanbul Medipol University, Istanbul, Turkey
Neveen Kohaf, Tanta, Egypt
Haney Baumey, Banhā, Egypt
Faculty of Medicine, Cairo University, Cairo, Egypt
Syed Muhammad Abbas, Karachi, Sindh, Pakistan
Benha university, Banhā, Qalubia, Egypt
Weitao Chen, Zhongshan, Guangdong, China
Beijing Hospital, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.